Home/Filings/4/0001209191-23-022749
4//SEC Filing

Belloff Neil S. 4

Accession 0001209191-23-022749

CIK 0001008848other

Filed

Apr 3, 8:00 PM ET

Accepted

Apr 4, 4:38 PM ET

Size

5.6 KB

Accession

0001209191-23-022749

Insider Transaction Report

Form 4
Period: 2023-03-31
Belloff Neil S.
General Counsel
Transactions
  • Award

    Employee Stock Option (right to buy)

    2023-03-31+77,30077,300 total
    Exercise: $0.59Exp: 2033-03-31Common Stock (77,300 underlying)
Footnotes (1)
  • [F1]Options issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares subject to the options vest in equal quarterly installments over two years beginning on January 1, 2023 with the first quarterly installment vesting on April 1, 2023.

Issuer

Acorda Therapeutics, Inc.

CIK 0001008848

Entity typeother

Related Parties

1
  • filerCIK 0001741670

Filing Metadata

Form type
4
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 4:38 PM ET
Size
5.6 KB